Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

BASKING RIDGE, N.J.& SHIRLEY, N.Y.--(BUSINESS WIRE) June 05, 2023 --Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved Injectafer®...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news